The FDA orders the recall of a nasal spray in the US after finding live microbes; immunocompromised patients are at greatest ...
Company Granted U.S. Patent for Its Spray Data Analysis and Characterization System, Version 4 Allows 21 CFR Part 11 Compliance and Reduces Overall Lab Testing Time by 10x Over Manual Methods ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback